Piramal directors give nod to raise to raise Rs 100 crore

Piramal Enterprises said Friday its directors have approved raising of up to Rs 100 crore via issue of securities. The meeting of committee of directors (Funding) today approved the issue of unsecured non-convertibledebentures (NDCs) aggregating up to Rs 100 crore on a private placement basis, Piramal Enterprises said in a regulatory filing. The company said […]

Read More →
Delhi HC extends stay on drug ban till March 28

The Delhi High Court on Monday extended the stay on the government’s decision to ban 344 fixed drug combinations (FDCs) till the next hearing on March 28. The government had banned these FDCs on March 10 after an expert panel found those to be lacking therapeutic effects as well as posing various health risks. Following […]

Read More →
Aurobindo Pharma gains on USFDA nod for Naproxen Sodium Tablets

Aurobindo Pharma AUROBINDO PHARMA LTD LIVE STOCK PRICE – CLICK HERE FOR MORE BSE 755.006.05 (0.81%) NSE 755.406.85 (0.92%) BSE NSE 09:3010:0010:3011:00740745750755760765 2Y1Y6M1M5D1D ALSO READ Aurobindo Pharma gains on USFDA nod for Aripiprazole tabletsAurobindo Pharma surges on USFDA nod for anti-HIV tabletsAurobindo’s anti-psychotic drug gets final approval from USFDAAurobindo gets final USFDA nod for anti-fungal […]

Read More →
Glenmark gets tentative nod from USFDA for epilepsy drug

GLENMARK PHARMACEUTICALS LTD LIVE STOCK PRICE – CLICK HERE FOR MORE BSE 832.4511.20 (1.36%) NSE 832.2511.10 (1.35%) BSE NSE 09:3010:0010:3311:03820825830835 2Y1Y6M1M5D1D ALSO READ Glenmark Pharma gets USFDA nod for two generic drugsGlenmark evaluating legal options over diabetes drugs setbackGlenmark gets final FDA nod for migraine headache relief drugGlenmark gets tentative nod from USFDA for azelaic […]

Read More →
Indoco Remedies rallies on USFDA nod for plant in Goa

Indoco Remedies has rallied 19% to Rs 314 on the National Stock Exchange (NSE) after the company received US Food and Drug Administration (USFDA) approval for Goa solid dosages plant. “The company has received the Establishment Inspection Report (approval) from US Food and Drug Administration (USFDA) for its solid dosages manufacturing facility at Goa (Plant […]

Read More →
Pharma shares extend fall; Lupin nears 52-week low

Shares of pharmaceutical companies remained under pressure in monring deals on Friday, with most of the frontline stocks trading lower by over 2% on the BSE. Sun Pharmaceutical Industries, Lupin, Aurobindo Pharma and Natco Pharma were down more than 3% each, while Wockhardt, Glenmark Pharmaceuticals, Indoco Remedies and Ajanta Pharma down between 2%-3% on the […]

Read More →
HC to hear pharma pleas against ban

The Delhi High Court is likely to resume tomorrow the hearing on pleas by over 30 pharma majors, including Pfizer, Glenmark, Procter and Gamble (P&G) and Cipla, challenging the government’s decision to ban sale of some of their fixed dose combination medicines. Justice Rajiv Sahai Endlaw, who has stayed operation of the government’s notification till […]

Read More →
Health-care stocks unlikely to rerate more

While the appetite for health-care stocks remains strong, the latest being HealthCare Global Enterprises, further re-rating of existing firms on the back of higher valuations sought by new firms is unlikely. Analysts say the recent re-rating of healthcare stocks has meant valuations have already factored in best-case scenarios. Sarabjit Kour Nangra of Angel Broking says […]

Read More →